ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 198

Accuracy Of International Classification Of Diseases (Ninth Revision) Coding For Rheumatoid Arthritis In The Primary Care Setting

Sheena Ogando1, Karolina M. Weiss1 and Harry D. Fischer2, 1Department of Medicine, Albert Einstein College of Medicine at Beth Israel Medical Center, New York, NY, 2Division of Rheumatology, Albert Einstein College of Medicine at Beth Israel Medical Center, New York, NY

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: DMARDs, ICD-9, primary care, Quality measures and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Health Services Research, Quality Measures and Quality of Care-Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Current quality measures are diagnosis driven and focus on management.  For rheumatoid arthritis (RA), the Physician Quality Reporting System requires that a disease modifying anti-rheumatic drug (DMARD) therapy be prescribed.  Quality measures do not account for incorrect diagnoses.  Diagnostic error can stem from a physician or from a patient report of a medical history.  Prior studies have shown a discrepancy between patient report and physician diagnosis.  One study reported diabetes – a well defined disease – had no variance, while arthritis – a less clearly defined disease – had a 15% variance, with patients over reporting the disease.  Our objective is to determine the accuracy of RA diagnosis in our institution’s primary care offices and to evaluate if quality measures are met.

Methods: Adult patients with the International Classification of Diseases, Ninth Revision (ICD-9) code for Rheumatoid Arthritis (714.0) were searched from April 2011 to April 2013 using our institution’s primary care electronic medical record.  The medication list was reviewed for the presence of a DMARD.  The paper chart of patients seen in our institution’s rheumatology clinic was reviewed for a more accurate diagnostic code.   

Results: 246 patients were identified by ICD-9 code using the primary care electronic medical record; 172 were used for evaluation.  The average age of the patient population was 60.4 with a standard deviation of 12.7.  88.4% (152) were female.  The rate of incorrect ICD-9 coding by primary care physicians was 24-38% [CI of 95%].  The top 5 rheumatologist established diagnoses in these patients were osteoarthritis (20), other inflammatory arthritis (10), undifferentiated connective tissue disease (8), osteoporosis/osteopenia (5), and systemic lupus erythematosus (5).   In patients with rheumatologist confirmed RA, 12-26% [CI of 95%] did not have a DMARD in the primary care medication list.

Conclusion: The high incidence of primary care physicians erroneously utilizing the 714.0 ICD-9 code in our institution can be attributed to inaccurate reporting of the disease by the patient and its usage to rule out the disease.  In 48 cases, a patient reported to their primary care physician that they suffered from rheumatoid arthritis when in fact they had another diagnosis.  These patients with inaccurate ICD-9 codes will be inappropriately categorized as receiving poor levels of care by not meeting RA quality measures.  In patients with true disease, a lower percentage is noted to not meet the quality measure of DMARD treatment.  Interestingly, it was observed that injectible medications were not documented in the primary care medication list.  This could be due to the fact that patients often bring physical bottles for medication reconciliation and not the injectables.  Taking this into consideration, the percentage of RA patients not meeting quality measures is likely considerably lower.  In conclusion, since quality measures do not address the issue of inaccurate diagnosis, its emphasis on management and its potentially associated penalties should be reevaluated.  Further studies are needed to determine if patients with inaccurate coding are subjected to unnecessary treatment or testing.


Disclosure:

S. Ogando,
None;

K. M. Weiss,
None;

H. D. Fischer,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/accuracy-of-international-classification-of-diseases-ninth-revision-coding-for-rheumatoid-arthritis-in-the-primary-care-setting/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology